Fatigue assessment in Egyptian patients with hepatitis C virus-related chronic liver disease: Single center study

Read full text Summarise with VIRAT
Authors: Marwa Ali Haseeb Tahoon, Sally Waheed Elkhadry, Eman Abdelsameea, Reham Ashour
Cited by: 0
References: 30

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND Chronic hepatitis C virus (HCV) infection is a significant global health concern, often associated with fatigue that influences patients' quality of life. AIM To assess prevalence of significant or severe fatigue in cases with HCV-related chronic liver disease and to detect factors independently related to fatigue using the multidimensional fatigue inventory (MFI-20). METHODS A cross-sectional study was conducted at the National Liver Institute, Menoufia University, Egypt, including 300 patients with chronic HCV infection. Participants with significant comorbidities or conditions impacting fatigue were excluded. Recruited participants completed a structured questionnaire on demographics, clinical and laboratory data with assistance from qualified physicians. Fatigue was evaluated in five domains (physical, general, reduced activity, decreased motivation and mental fatigue) using the MFI-20. Liver dysfunction severity was categorized using Child-Pugh and model for end stage liver disease (MELD) scores and liver fibrosis (FIB) was assessed via the FIB-4 index. Data were analyzed using descriptive and comparative statistics and multivariate regression. RESULTS Significant/severe fatigue was prevalent in 27.3% of chronic HCV patients. A higher MELD score, presence of a history of gastrointestinal bleeding, ascites, lack of antiviral treatment response, hepatic encephalopathy, antiviral treatment within the past year, and longer HCV infection were significantly associated with significant/severe fatigue. Decompensated liver disease, intermediate/high-risk FIB, < 1 year duration of last dose of antiviral treatment, and HCV infection duration were independent risk factors for fatigue. CONCLUSION Fatigue is highly prevalent among HCV-related chronic liver disease patients. Using the MFI-20, we revealed that fatigue severity is independently associated with liver disease severity, antiviral treatment, and infection duration. This highlights the necessity of regular fatigue assessment in clinical practice.

Fields of Study & Subjects

Hepatitis C virus research Liver Disease and Transplantation Liver Disease Diagnosis and Treatment

Publication details

Journal / source
World Journal of Hepatology
Volume
18
Issue
3
Publication date
26 March 2026
Language
EN